Ocular Therapeutix OCUL Operating margin

Operating margin at other companies

Regeneron PharmaceuticalsREGN

24.7%-2.3pp

EyePoint, Inc.EYPT

-11,365.2%-11,754pp

Bausch + LombBLCO

6.1%+5.3pp

HRO

HarrowHROW

7.3%+5.2pp

Tarsus Pharmaceuticals, Inc.TARS

-8%-3.5pp

PTH

Pelthos TherapeuticsPTHS

-157.7%—

FAQ

What is Ocular Therapeutix's operating margin?

Ocular Therapeutix (OCUL) reported operating margin of -575.4% in Q1 2026.

How has Ocular Therapeutix's operating margin changed year-over-year?

Ocular Therapeutix's operating margin decreased by 68.2% year-over-year, from -342.2% to -575.4%.

What is the long-term trend for Ocular Therapeutix's operating margin?

Over 5 years (2020 to 2025), Ocular Therapeutix's operating margin has grown at a 7.6% compound annual growth rate (CAGR), from -361.1% to -519.8%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.